Latest Articles
8 articles published
NVIDIA Releases NemoClaw to Improve OpenClaw's Security
NemoClaw is NVIDIA’s security focused runtime for OpenClaw agents, introduced at GTC. It addresses a growing problem with autonomous agents running with broad permissions. As OpenClaw adoption increased, so did concerns around data access, execution safety, and uncontrolled behavior. NemoClaw adds a structured layer that enforces how agents interact with systems and external services. At its core, NemoClaw uses OpenShell to run agents inside sandboxed environments. Every action, including file access, network calls, and model inference, is governed by policy. Inference requests are routed through a gateway instead of direct calls, allowing better control over privacy and provider usage. This design shifts responsibility from the developer to the runtime. While setup is still rough in early preview, the direction is clear. NemoClaw brings predictability, security, and reproducibility to agent workflows. For developers and enterprises running always on agents, it provides the control needed to move from experimentation to real deployment.
This is a test article
This is a title excerpt
GPT-5 Achieves Human-Level Reasoning on Benchmark Suite
OpenAI has released GPT-5, which demonstrates unprecedented reasoning capabilities across math, science, and common-sense tasks, raising new questions about AGI timelines.
Anthropic Publishes Constitutional AI v2 Framework
Anthropic's updated Constitutional AI framework introduces self-critique mechanisms and multi-turn preference learning to produce safer, more aligned language models.
EU AI Act Enforcement Phase Begins for High-Risk Systems
The European Union's AI Act has entered its first enforcement phase, requiring companies deploying high-risk AI systems to register with national authorities and submit conformity assessments.
Google DeepMind Unveils Gemini-Powered Multimodal Agents
Google DeepMind has demonstrated a new generation of Gemini-powered agents capable of executing complex multi-step tasks combining vision, language, and code generation.
The Open-Source LLM Landscape in 2025: Who's Winning?
A deep dive into the current state of open-source large language models — benchmarks, licensing, deployment, and community adoption.
AI-Discovered Drug Compounds Enter Phase II Clinical Trials
Drug candidates identified using generative AI models have progressed to Phase II clinical trials, marking a significant milestone in AI-accelerated pharmaceutical development.